Tuesday, February 28, 2006


ViRexx Presents Hepatitis C Chimigen'TM' Technology at Baculovirus ... (Hep C Chronic Fatigue)


ViRexx Presents Hepatitis C Chimigen'TM' Technology at Baculovirus ...
Genetic Engineering News, NY - Feb 22, 2006... The presentation is titled "Properties of a Chimigen(TM) Vaccine Produced in Insect Cells for the Treatment of Chronic Hepatitis C Infections". ...

Idenix and Novartis Seek European Approval of Telbivudine for the ...
PR Newswire (press release), NY - Feb 7, 2006... of other product candidates in Idenix's portfolio, including valopicitabine (NM283), a direct antiviral for the treatment of chronic hepatitis C. About Idenix ...

Peregrine Antiviral Demonstrates Safety in Hepatitis Patients
International News Service, Australia - 18 hours ago... data demonstrating that its first-in-class antiviral compound Tarvacin appeared safe and well-tolerated in a phase I study in patients with chronic hepatitis C ...

Coley Pharmaceutical Group Initiates Phase II Clinical Study of ...
PR Newswire (press release), NY - Feb 23, 2006... announced the initiation of a randomized Phase II clinical study of Actilon(TM) (CPG 10101) for the treatment of patients with chronic Hepatitis C infection. ...

CME Questions
AAP Grand Rounds (subscription) - Feb 9, 2006... completion: Describe the efficacy of interferon alpha-2b in combination with ribavirin for treatment of chronic hepatitis C in children. ...